Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer. [electronic resource]
- BMC cancer May 2010
- 185 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1471-2407
10.1186/1471-2407-10-185 doi
Adult Aged Antineoplastic Combined Chemotherapy Protocols--therapeutic use CA-125 Antigen--blood Carboplatin--administration & dosage Carcinoma--chemistry Chemotherapy, Adjuvant Cyclophosphamide--administration & dosage Female Gynecologic Surgical Procedures Humans Immunohistochemistry Kaplan-Meier Estimate Membrane Proteins--blood Middle Aged Ovarian Neoplasms--chemistry Randomized Controlled Trials as Topic Second-Look Surgery Time Factors Tissue Array Analysis--methods Tissue Inhibitor of Metalloproteinase-1--analysis Treatment Outcome